ULBI Ultralife PE ratio, current and historical analysis
- Stocks
- Industrials
- NASDAQ: ULBI
- PE Ratio
The PE ratio for Ultralife stock stands at 28.34 as of Jul 3, 2025. This takes into account the latest EPS of $0.32 and stock price of $9.07. An increase of 61% has been observed in the PE ratio compared to its average of 17.6 of the last four quarters.
ULBI PE ratio history
Over the last ten years, the average PE ratio of Ultralife has been 20.54. The current 28.34 P/E ratio is 38% higher than the historical average. Looking back at the last ten years, ULBI's PE ratio peaked in the Sep 2021 quarter at 39.56, with a price of $7.12 and an EPS of $0.18. The Dec 2018 quarter marked the lowest point at 4.3, with a price of $6.75 and an EPS of $1.57.
Ultralife PE ratio by year
Maximum annual increase: 420.7% in 2019
Maximum annual decrease: -67.84% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 19.61 | 26.52% | $7.45 | $0.38 |
| 2023 | 15.5 | N/A | $6.82 | $0.44 |
| 2022 | N/A | N/A | $3.86 | -$0.01 |
| 2021 | N/A | N/A | $6.04 | -$0.01 |
| 2020 | 19.61 | -12.42% | $6.47 | $0.33 |
| 2019 | 22.39 | 420.7% | $7.39 | $0.33 |
| 2018 | 4.3 | -67.84% | $6.75 | $1.57 |
| 2017 | 13.37 | -37.87% | $6.55 | $0.49 |
| 2016 | 21.52 | -40.04% | $4.95 | $0.23 |
| 2015 | 35.89 | N/A | $6.46 | $0.18 |
| 2014 | N/A | N/A | $3.13 | -$0.12 |
| 2013 | N/A | N/A | $3.55 | -$0.05 |
| 2012 | N/A | N/A | $3.24 | -$0.09 |
| 2011 | N/A | N/A | $4.02 | -$0.12 |
| 2010 | N/A | N/A | $6.61 | -$0.36 |
Ultralife PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 16.81 | -14.28% | $5.38 | $0.32 |
| Dec 2024 | 19.61 | 19.28% | $7.45 | $0.38 |
| Sep 2024 | 16.44 | -5.57% | $9.04 | $0.55 |
| Jun 2024 | 17.41 | 26.43% | $10.62 | $0.61 |
| Mar 2024 | 13.77 | -11.16% | $8.81 | $0.64 |
| Dec 2023 | 15.5 | -60.3% | $6.82 | $0.44 |
| Sep 2023 | 39.04 | 29.06% | $9.76 | $0.25 |
| Jun 2023 | 30.25 | N/A | $4.84 | $0.16 |
| Mar 2023 | N/A | N/A | $4.02 | -$0.02 |
| Dec 2022 | N/A | N/A | $3.86 | -$0.01 |
| Sep 2022 | N/A | N/A | $4.81 | -$0.06 |
| Jun 2022 | N/A | N/A | $4.55 | -$0.09 |
| Mar 2022 | N/A | N/A | $5.37 | -$0.07 |
| Dec 2021 | N/A | N/A | $6.04 | -$0.01 |
| Sep 2021 | 39.56 | 18.02% | $7.12 | $0.18 |
ULBI Price vs fair value
ULBI average PE ratio chart
Currently, ULBI's PE ratio is higher than the 3, 5 and 10-year averages.
ULBI PE vs peers
ULBI's PE ratio stands lower than its peer stock ENR, but it is higher than BDC's and ENS's. Ultralife is currently trading at a higher PE ratio (28.34) than its peers average of 18.97.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ENS EnerSys | 9.86 | $3.54B |
| EPC EDGEWELL PERSONAL CARE Co | 14.23 | $1.16B |
| BDC Belden Inc | 23.11 | $4.81B |
| ULBI Ultralife Corp | 28.34 | $150.86M |
| ENR Energizer Holdings Inc | 28.68 | $1.55B |
Frequently asked questions
What is Ultralife's PE ratio?
ULBI stock has a price to earnings ratio of 28.34 as of Jul 3, 2025.
What is the 3-year average PE ratio for Ultralife (ULBI)?
Over the last 3 years, the average price to earnings ratio for ULBI stock is 21.1.
What is the 5-year average PE ratio for Ultralife (ULBI)?
Over the last 5 years, the average price to earnings ratio for ULBI stock is 23.75.
What is the highest PE ratio for ULBI?
Over the last ten years, the quarterly PE ratio reached its highest level at 39.56 in the Sep 2021 quarter.
How does the current PE ratio for ULBI compare to its historical average?
ULBI's price to earnings ratio is currently 38% above its 10-year historical average.
How is ULBI's PE ratio calculated (Ultralife PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jul 3, 2025), Ultralife's share price is $9.07. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.32. Therefore, Ultralife's PE ratio for today is 28.34. PE RATIO(28.34) = STOCK PRICE($9.07) / TTM EPS($0.32)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.